Daily non-political popular news in brief.

HORIZONS AMI trial data will help set guidelines

Late-breaking data presented at TCT 2007, the scientific symposium of the Cardiovascular Research Foundation, show that the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduces net adverse clinical events by 24 percent compared to the standard treatment, and significantly reduces major bleeding that occurs after angioplasty by 40 percent.

Read more »

Keywords: horizons, ami, trial, data, set, guidelines, horizon, guideline

« Previous | Next »

Similar news on "HORIZONS AMI trial data will help set guidelines":

1. Horizons AMI trial data to be presented at TCT 2007
   10-15-2007 · EurekAlert!
   The study is designed to examine the safety and effectiveness of stents and anticoagulants in heart attack patients undergoing angioplasty.
   Similar news · Read more »
   
2. RAND study finds school playgrounds can help fight childhood obesity
   04-19-2007 · EurekAlert!
   A RAND Corp. study issued today says school playgrounds and athletic facilities can be important tools in the fight against childhood obesity, but many are locked and inaccessible to children on weekends -- especially in poor and minority neighborhoods.The study is a new analysis of data from a national research study called the Trial of Activity for Adolescent Girls.
   Similar news · Read more »
   
3. Novel transfusion strategy for pediatric patients in intensive care
   04-19-2007 · EurekAlert!
   Before this study, entitled "TRIPICU (Transfusion Requirements for Patients in Pediatric Intensive Care Units)," no precise data were available to guide intensive care specialists when deciding about whether or not to transfuse critically ill children. The results of this trial are published today in the New England Journal of Medicine by Dr. Jacques Lacroix, a professor at the Université de Montréal and a pediatric intensivist as well as researcher at the CHU Sainte-Justine.
   Similar news · Read more »
   
4. DOE JGI sets 'gold standard' for metagenomic data analysis
   05-14-2007 · EurekAlert!
   The field of metagenomics is still in its infancy -- the equivalent of the early days of the California Gold Rush, with labs vying to stake their claim. Amidst the prospecting, the call has been issued for methods to separate fool's gold from the real nuggets. Such a gold standard has now been set and published by the US Department of Energy Joint Genome Institute with colleagues in the May edition of Nature Methods.
   Similar news · Read more »
   
5. Fosrenol does not further impact cognitive function deterioration in CKD Stage 5 patients
   10-18-2006 · EurekAlert!
   Newly published data from a large, two-year trial in the November Kidney International report on the effects of chronic kidney disease on cognitive function in CKD Stage 5 patients with hyperphosphatemia (high serum phosphorus levels in the blood), treated with phosphate binder therapy. This study is particularly relevant, as there is evidence that individuals with reduced renal function experience a significantly greater decline in cognitive function compared to those with normal renal function.
   Similar news · Read more »
   
6. New data show ACTOS(r) (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
   11-13-2006 · EurekAlert!
   Researchers today presented data showing that ACTOS® (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid intima-media thickness (CIMT) in patients with type 2 diabetes. Results from the clinical trial, CHICAGO (Carotid intima-media tHICkness in Atherosclerosis using pioGlitazOne), are part of a late-breaker presentation at the American Heart Association's Scientific Sessions 2006, coincidentally being held in Chicago, and coincide with an early online issue of the Journal of the American Medical Association.
   Similar news · Read more »
   
7. A roadmap for calibration and validation
   10-22-2007 · EurekAlert!
   The volume of data acquired by more than 50 Earth observation satellites is increasing at an exponential rate and is providing unprecedented synoptic views of our planet. Because these satellites often use different methodologies, using data for trend analysis and environmental monitoring can be difficult, making it essential to establish globally-recognized guidelines for calibration and validation processes.
   Similar news · Read more »
   
8. Half of patients with active early rheumatoid arthritis achieved clinical remission
   11-07-2007 · EurekAlert!
   Amgen and Wyeth Pharmaceuticals, a division of Wyeth, today announced that data from a multicenter, randomized, double-blind trial of ENBREL plus methotrexate showed that 50 percent of patients with active early rheumatoid arthritis achieved clinical remission at one year.
   Similar news · Read more »
   
9. 1-year results of bronchial thermoplasty in refractory asthma
   02-11-2008 · EurekAlert!
   Data from the Research in Severe Asthma trial of bronchial thermoplasty published in the American Journal of Respiratory and Critical Care Medicine show that patients experienced long term improvement in pulmonary function, improved quality of life and asthma control, and a reduction in rescue medication use for patients treated with bronchial thermoplasty.
   Similar news · Read more »
   
10. Long-awaited international ethical guidelines for biobank researchers
    09-14-2007 · EurekAlert!
    Many sets of guidelines and regulations, and great differences among countries. This is what medical researchers encounter if they want to use previously collected samples from biobanks in their research. For one thing, this makes it extremely complicated to carry out major international studies. In the latest issue of Nature Biotechnology, Swedish ethics researchers at the Center for Bioethics, together with leading biobank researchers, put forward a pioneering solution: a set of practical ethical guidelines for biobank research.
    Similar news · Read more »